Luis M. Vilá to Immunosuppressive Agents
This is a "connection" page, showing publications Luis M. Vilá has written about Immunosuppressive Agents.
Connection Strength
2.139
-
Varela-Rosario N, P?rez-Berenguer JL, Vil? LM. Efficacy of immunosuppressive treatment in a systemic lupus erythematosus patient presenting with inclusion body myositis. BMJ Case Rep. 2016 Apr 05; 2016.
Score: 0.471
-
V?zquez-Sanabria IL, Mercado-Seda R, Varela-Rosario N, Vil? LM. Efficacy of intravenous immunoglobulins in a patient with systemic lupus erythematosus presenting with Stevens-Johnson syndrome. BMJ Case Rep. 2015 Jul 22; 2015.
Score: 0.449
-
Santiago-Casas Y, Peredo RA, Vil? LM. Efficacy of low-dose intravenous cyclophosphamide in systemic lupus erythematosus presenting with Guillain-Barre syndrome-like acute axonal neuropathies: report of two cases. Lupus. 2013 Mar; 22(3):324-7.
Score: 0.380
-
Castro-Santana LE, Col?n M, Molina MJ, Rodr?guez VE, Mayor AM, Vil? LM. Efficacy of two cyclophosphamide regimens for the treatment of lupus nephritis in Puerto Ricans: low vs. standard dose. Ethn Dis. 2010; 20(1 Suppl 1):S1-116-21.
Score: 0.305
-
V?zquez-Otero I, Medina-Cintr?n N, Arroyo-?vila M, Gonz?lez-Sep?lveda L, Vil? LM. Clinical impact of hydroxychloroquine dose adjustment according to the American Academy of Ophthalmology guidelines in systemic lupus erythematosus. Lupus Sci Med. 2020 05; 7(1).
Score: 0.156
-
Gago R, Shum LM, Vil? LM. Right upper quadrant abdominal pain as the initial presentation of polyarteritis nodosa. BMJ Case Rep. 2017 Feb 22; 2017.
Score: 0.125
-
L?pez-L?pez L, Rivera-Rodr?guez N, Vil? LM. Nitrofurantoin-induced microangiopathic haemolytic anaemia and thrombocytopaenia in a patient with systemic lupus erythematosus. BMJ Case Rep. 2012 Sep 12; 2012.
Score: 0.092
-
Gonz?lez LA, Pons-Estel GJ, Zhang JS, McGwin G, Roseman J, Reveille JD, Vil? LM, Alarc?n GS. Effect of age, menopause and cyclophosphamide use on damage accrual in systemic lupus erythematosus patients from LUMINA, a multiethnic US cohort (LUMINA LXIII). Lupus. 2009 Feb; 18(2):184-6.
Score: 0.072
-
Alarc?n GS, Ugarte-Gil MF, Pons-Estel G, Vil? LM, Reveille JD, McGwin G. Remission and low disease activity state (LDAS) are protective of intermediate and long-term outcomes in SLE patients. Results from LUMINA (LXXVIII), a multiethnic, multicenter US cohort. Lupus. 2019 Mar; 28(3):423-426.
Score: 0.036
-
Vil? LM, Mayor AM, Valent?n AH, Garc?a-Soberal M, Vil? S. Clinical and immunological manifestations in 134 Puerto Rican patients with systemic lupus erythematosus. Lupus. 1999; 8(4):279-86.
Score: 0.036
-
Gonz?lez LA, McGwin G, Dur?n S, Pons-Estel GJ, Apte M, Vil? LM, Reveille JD, Alarc?n GS. Predictors of premature gonadal failure in patients with systemic lupus erythematosus. Results from LUMINA, a multiethnic US cohort (LUMINA LVIII). Ann Rheum Dis. 2008 Aug; 67(8):1170-3.
Score: 0.017